SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SPARC to raise funds up to Rs 250 crore through rights issue

13 May 2015 Evaluate

Sun Pharma Advanced Research Company (SPARC) has received an approval for further issuance of equity shares of Re 1 each of the company, on rights basis to the shareholders of the company on such ratio and at such price and premium as may be decided in consultation with the Lead Managers to the proposed rights issue, so that the funds raised by way of right issue of shares is not more than Rs 250 crore. The board of directors at their meeting held on May 12, 2015 has approved for the same.

Sun Pharma Advanced Research Company (SPARC) is an international pharmaceutical company engaged in research and development of drugs and delivery systems.



Sun Pharma Adv. Res Share Price

144.55 -3.35 (-2.27%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 436.55
Indegene 482.65
CMS Info Systems 317.60
JITF Infralogistics 331.25
Sagility 42.17
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×